Johnson & Johnson (JNJ)

163.87
+3.75(+2.34%)
After Hours
163.87
0.00(0.00%)
- Real-time Data
  • Volume:
    10,017,311
  • Bid/Ask:
    163.87/163.91
  • Day's Range:
    160.73 - 165.15

JNJ Overview

Prev. Close
160.12
Day's Range
160.73-165.15
Revenue
89.19B
Open
160.9
52 wk Range
133.65-179.92
EPS
6.65
Volume
10,017,311
Market Cap
421.51B
Dividend (Yield)
4.24
(2.63%)
Average Volume (3m)
5,863,171
P/E Ratio
24.08
Beta
0.71
1-Year Change
8.12%
Shares Outstanding
2,632,482,092
Next Earnings Date
18 Oct 2021
What is your sentiment on Johnson & Johnson?
or
Market is currently closed. Voting is open during market hours.

Johnson & Johnson News

Johnson & Johnson Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyBuyNeutralBuy
Technical IndicatorsStrong BuySellStrong BuySellBuy
SummaryStrong BuyNeutralStrong BuyNeutralBuy

Johnson & Johnson Company Profile

Johnson & Johnson Company Profile

Employees
134500

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the skin health/beauty, over-the-counter medicines, baby care, oral care, women’s health and wound care markets. The Pharmaceutical segment is focused on six immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism and pulmonary hypertension. The Medical Devices segment includes a range of products used in the interventional solutions, orthopedic, surgery, and vision fields.

Read More
  • FDA approved finally. Few minutes ago!!!!
    0
    • Invested in J&J a couples years back and have closely followed the pharmaceutical industry. Found a company by the name of SpectrumX which has an IPO set for November. SpectrumX are leaders in patented shielded HOCL formulations that have numerous applications in medical/pharma fields. They have also undergone 2 clinical trails for Covid-19 treatment (apparently not factored into the company valuation.) To me this company seems to be on track for high growth after the IPO, however I may be getting lost in the hype. Would love to hear people's thoughts on the stock as I am keen to invest early.
      0
      • To entry in Spectrum or not? What do you think?
        0
      • Checking it out looks like a good punt
        0
    • Good job JNJ. move forward bullish
      0
      • Stock split???
        0
        • Where we go next?
          0
          • AMC! But ultimately it’s your decision.
            0
        • Good buy. 0at this price
          0
          • JNJ is going to Make a strong come back tonight!
            1
            • Immediate inquiry must be done
              4
              Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
              Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.